Problematic Use and Addiction in Primary Care
Launched by UNIVERSITY HOSPITAL, TOURS · Aug 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Problematic Use and Addiction in Primary Care," aims to improve the early detection of addiction disorders in primary care settings. The goal is to help healthcare professionals, like doctors, nurses, and pharmacists, identify signs of addiction more effectively. By training these professionals, the study hopes to reduce the negative effects of addiction on patients' health and well-being.
To participate in this trial, you need to be a primary care professional, such as a general practitioner, physiotherapist, or nurse, working in an outpatient setting. Participants will be randomly divided into two groups: one will receive special training on identifying addiction disorders, while the other group will not. The trial is designed to ensure that the healthcare professionals involved reflect the diverse practices found in primary care. This study is important because it seeks to address the current challenges in recognizing addiction early, ultimately improving the quality of care for patients who may be struggling with these issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • be a primary care professional (physiotherapists, nurses, midwives, dentists, pharmacists, General practitioner)
- • in ambulatory practice. Recruitment will be carried out with the help of territorial professional health communities, to include practitioners practicing in conditions representative of the diversity of primary care practice.
- • GPs agreeing to take part will be divided into a control group and an intervention group, by drawing lots.
- Exclusion Criteria:
- • Refusal to participate.
- • The same participant may not be included in more than one stage.
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lanmeur, , France
Ligueil, , France
Vendôme, , France
Patients applied
Trial Officials
Maxime PAUTRAT
Principal Investigator
Tours university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported